Laurent van Lerberghe
Laurent is a seasoned digital health investor and strategic leader with over 25 years of pharma C-suite experience, including transformative roles as Chief Strategy Officer at Sanofi and Commercial VP at Abbott.
Throughout his career, Laurent has been a driving force in healthcare innovation, shaping the strategies of major corporations and delivering results across the US, Europe, and Asia.
At Sanofi, he led pivotal initiatives, including the creation of the Gene Therapy Unit and orchestrating acquisitions that expanded the company’s footprint in oncology, immunology, and digital health, and raised Sanofi’s stock value to historic heights.
Laurent is a seasoned digital health investor and strategic leader with over 25 years of pharma C-suite experience, including transformative roles as Chief Strategy Officer at Sanofi and Commercial VP at Abbott.
Throughout his career, Laurent has been a driving force in healthcare innovation, shaping the strategies of major corporations and delivering results across the US, Europe, and Asia.
At Sanofi, he led pivotal initiatives, including the creation of the Gene Therapy Unit and orchestrating acquisitions that expanded the company’s footprint in oncology, immunology, and digital health, and raised Sanofi’s stock value to historic heights.
Articles: Laurent van Lerberghe
How UK–French Ambition Can Create Europe’s Silicon Valley
UK / Europe risks “slow death” in innovation unless it builds its own Silicon Valley, argues digital health investor Laurent van Lerberghe. With Macron pushing Anglo-French tech sovereignty, the UK and France have the talent, capital, and healthcare ecosystems to lead. By linking their world-class clusters, aligning regulation, and pooling investment, they could create a trans-Channel powerhouse…
Latest Report
